Medix Biochemica Appoints Lonnie Shoff, Seasoned Healthcare Executive to its Board of Directors

• Medix Biochemica announces that Lonnie Shoff, former President of the Clinical Diagnostics Division at Thermo Fisher Scientific has been appointed to its Board of Directors.
• Ms Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics.

Medix Biochemica, a global leader in critical in vitro diagnostics (IVD) raw materials, has announced the appointment of Lonnie Shoff to their Board of Directors. Lonnie is a seasoned healthcare executive with more than 30 years of international experience gained at large multi-national companies such as Roche, Thermo Fisher Scientific and Mars Petcare.

She brings expertise in corporate strategy, transformational change management, commercial execution, and B2B partnerships relevant to the in vitro diagnostics industry. With a successful track record of leading and profitably growing businesses in both emerging and mature markets, Lonnie has previously held President and CEO level roles at Thermo Fisher Scientific and Henry Schein, as well as senior roles at Roche, including General Manager and Regional Head.

“I am delighted to be joining the Board of Directors of Medix Biochemica. I have long admired the broad offering and stellar quality of the Medix Biochemica portfolio and am honored to be offered the opportunity to be a part of the company’s exciting future,”

says Ms Lonnie Shoff.

“The Board of Medix Biochemica has governed the transformation of our company to be a truly international partner to IVD manufacturers. Ms Shoff’s appointment is a continuation in the active development of Medix Biochemica towards our vision to become the most attractive partner for the IVD industry,”

says Ann-Christine Sundell, Chairperson, Medix Biochemica Board of Directors.

For more information visit www.medixbiochemica.com‍

‍About Medix Biochemica

With Finnish roots and rapidly growing global branches, Medix Biochemica is a market-leading, independent supplier of critical raw materials to the in vitro diagnostics (IVD) industry worldwide. We develop, produce, and supply high-quality antibodies, antigens, and other critical IVD raw material products to our IVD partners all around the world, enabling the delivery of accurate IVD tests to billions of patients worldwide. Our expertise covers everything from immuno- and molecular diagnostic reagents to biospecimen and custom services. With the most comprehensive raw material portfolio in the IVD world, and a team made up of the best minds in the business, we help shorten our customers’ time to market and build quality into every one of their tests. Medix Biochemica Group employs over 250 professionals worldwide and we serve our global customers through our local teams in North America, Europe, and China.

Contact information

Steve Ferguson, CEO Medix Biochemica
Phone: +358 9 547 680
Email: steve.ferguson@medixbiochemica.com